This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: AXP COF CSCO HPQ VZ

Stocks in this article: AXP COF CSCO HPQ VZ DE EMC IBM

Hess (HES) upgraded at Credit Suisse from underperform to neutral. $68 price target. Net asset value is improving.

HopFed Bancorp (HFBC) upgraded to buy at TheStreet Ratings.

Hewlett-Packard (HPQ) upgraded at JP Morgan from underweight to neutral. $21 price target. Headline news will likely not get worse going forward.

H&R Block (HRB) downgraded at Morgan Stanley to underweight from equal-weight. $17 price target. IRS delays and stock run creates unattractive risk reward.

Huntsman (HUN) downgraded at Wells Fargo to market perform from overweight. $17-$19 price target. Valuation call.

IBM (IBM) downgraded at JP Morgan from overweight to neutral. $197 price target. Company has relatively lower growth potential.

Incyte (INCY) upgraded at Lazard from neutral to buy. $25 price target. Jakafi should see earlier adoption.

Intuitive Surgical (ISRG) upgraded at Lazard to buy, Lazard Capital Markets said. $600 price target. Stock is attractive, following a 10% pullback.

JDS Uniphase (JDSU) downgraded at Goldman from buy to neutral, Goldman Sachs said. Valuation call, based on a $14 price target.

Louisiana-Pacific (LPX) downgraded at DA Davidson from neutral to underperform, DA Davidson said. $18 price target. Recent move is strand board prices is likely not sustainable.

Maxim (MXIM) downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. $31 price target. Expect significant deterioration in the handset market.

Nucor (NUE) upgraded at Keybanc from hold to buy, Keybanc said. Company is leveraged to lagging commercial construction markets. $56 price target.

Old Dominion (ODEL) downgraded at Deutsche from buy to hold, Deutsche Bank said. Valuation call, based on a $40 price target.

Pharmacyclics (PCYC) downgraded at Lazard to neutral. Company lacks near-term catalysts.

Parexel (PRXL) upgraded at Goldman from sell to neutral, Goldman Sachs said. $36 price target. Company can continue to expand margins over the coming quarters.

Reliance Steel (RS) downgraded at Keybanc from buy to hold. Estimates also cut, given a lower pricing environment.

Sprint (S) downgraded at UBS to neutral from buy, UBS said. $6 price target. 2013 outlook/operational challenges should keep shares range bound in 1H.

Sprint downgraded at JP Morgan from overweight to neutral, JP Morgan said. $6 price target. Sales growth is decelerating.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs